CDXS.NASDAQCodexis, INC

Form 4: Opaleye Management Inc. Increases Stake in Codexis, Inc. (CDXS)

Sentiment:

SEC Form 4


Opaleye Management Inc., a 10% owner of Codexis, Inc., reports purchasing additional shares of common stock on September 18, 2024.

Summary

  • Opaleye Management Inc. filed a Form 4 disclosing changes in beneficial ownership of Codexis, Inc. (CDXS) stock.
  • On September 18, 2024, Opaleye Management Inc. purchased 55,000 shares of common stock at a weighted average price of $3.1638 per share, with prices ranging from $3.0883 to $3.22.
  • These shares were acquired by Opaleye, L.P.
  • Additionally, 6,000 shares were purchased for a managed account at the same weighted average price.
  • Following these transactions, Opaleye, L.P. directly owns 7,380,000 shares, and the managed account owns 205,000 shares.
  • Opaleye Management Inc. disclaims beneficial ownership of these shares except to the extent of its pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The purchase indicates confidence from a major shareholder, but the disclaimer of beneficial ownership tempers the enthusiasm.

Positives

  • Opaleye Management Inc.'s increased investment in Codexis could be interpreted as a positive signal about the company's prospects.

Risks

  • Opaleye Management Inc. disclaims beneficial ownership except to the extent of its pecuniary interest, which could indicate a limited commitment.

Management Comments

  • Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein.

Industry Context

This filing reflects investment activity in the biotechnology sector, where Codexis operates. Monitoring ownership changes can provide insights into investor sentiment towards the company and the broader industry.

Comparison to Industry Standards

  • Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders and significant shareholders, ensuring transparency in the market.
  • Opaleye Management's investment activity can be compared to similar filings by other institutional investors in the biotechnology sector to gauge relative interest and conviction in different companies.

Stakeholder Impact

  • The increased stake by Opaleye Management Inc. could positively influence shareholder confidence.
  • The filing provides transparency to all stakeholders regarding ownership changes.

Key Dates

DateDescription
09/18/2024Date of stock purchase transactions.
09/19/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.